pany's ongoing portfolio
management activities. In November 2007, the Company's Board of Directors
granted the Company the authority to sell this business to its partner
based on achieving certain contractual terms and conditions. On 11 December
2007, the Company announced it had signed a definitive agreement to sell
its interest in its vinyl acetate ethylene (VAE) polymers joint ventures to
Wacker Chemie AG, its long-time joint venture partner. As part of the
agreement, the Company will receive Wacker Chemie AG's interest in the
Elkton, Md., and Piedmont, S.C., production facilities and their related
businesses plus cash considerations of $265. The sale, which is subject to
regulatory approvals and customary closing conditions, is expected to close
in the second quarter of fiscal year 2008. The Company anticipates a gain
on the sale of the Polymer Emulsions business in the range of $65 to $85
($42 to $55 after-tax).
In the first quarter of 2008, this business generated sales of $151.2
and income, net of tax, of $6.8.
The sale consists of the global VAE polymers operations including
production facilities located in Calvert City, Ky.; South Brunswick, N.J.;
Cologne, Germany; and Ulsan, Korea; and commercial and research
capabilities in Allentown, Pa., and Burghausen, Germany. The business
produces VAE for use in adhesives, paints and coatings, paper and carpet
applications.
Upon completion of the sale, the Company will assume full ownership of
the Elkton and Piedmont plants and related North American atmospheric
emulsions and global pressure sensitive adhesives business. The Company
intends to sell these businesses.
3. PENSION SETTLEMENT
A number of senior managers and others who were eligible for
supplemental pension plan benefits retired in fiscal year 2007. The
Company's supplemental pension plan provides for a lump sum benefit payment
option at the time of retirement, or for corporate officers six months
after the participant's
'/>"/>
SOURCE Air Products Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Related medicine news :1.
Makers of OTC Cough Medicines Reaffirm Efficacy of Products2.
DSS Announces Market Research Program for the Design of 2009 MA and PDP Products and Marketing Programs3.
Jan Marini Skin Research Suspends Sales of Popular Eyelash Products4.
Fusion Energy Teams Up With BPs am/pm Stores to Enhance Supercross Sponsorship and Fusion Energy Products Distribution5.
U.S. Food Safety: A Grocery List of Tainted Products6.
Statement From the Consumer Healthcare Products Association on the SAMHSA Findings on Cough Medicine Abuse7.
Align Technology Previews New Invisalign Products at JPMorgan Healthcare Conference8.
ReBuilder Medical Technologies, Inc. Expands R&D of New Products9.
Stress reduction products and services that are effective and safe10.
New ingredients in drug-like anti-aging products improve skin11.
Varian Medical Systems Acquires Pan-Pacific Enterprises for Marketing, Sales and Distribution of X-Ray Imaging Products in China